Zobrazeno 1 - 10
of 806
pro vyhledávání: '"Eugene, Schneider"'
Autor:
Pirou, G
Publikováno v:
Revue d'économie politique, 1936 Jan 01. 50(1), 278-279.
Externí odkaz:
https://www.jstor.org/stable/24688283
Autor:
Brunet, Pierre
Publikováno v:
Revue d'histoire des sciences et de leurs applications, 1947 Oct 01. 1(2), 192-192.
Externí odkaz:
https://www.jstor.org/stable/23903484
Autor:
Riley, H. L.
Publikováno v:
Science Progress (1933- ), 1946 Oct 01. 34(136), 824-824.
Externí odkaz:
https://www.jstor.org/stable/43421553
Autor:
Nicholas J. Viney, Shuling Guo, Li‐Jung Tai, Brenda F. Baker, Mariam Aghajan, Shiangtung W. Jung, Rosie Z. Yu, Sheri Booten, Heather Murray, Todd Machemer, Sebastien Burel, Sue Murray, Gustavo Buchele, Sotirios Tsimikas, Eugene Schneider, Richard S. Geary, Merrill D. Benson, Brett P. Monia
Publikováno v:
ESC Heart Failure, Vol 8, Iss 1, Pp 652-661 (2021)
Abstract Aims Amyloidogenic transthyretin (ATTR) amyloidosis is a fatal disease characterized by progressive cardiomyopathy and/or polyneuropathy. AKCEA‐TTR‐LRx (ION‐682884) is a ligand‐conjugated antisense drug designed for receptor‐mediat
Externí odkaz:
https://doaj.org/article/3297462a8e6e4c1081fbb6040b37c72e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
John K. Diep, Rosie Z. Yu, Nicholas J. Viney, Eugene Schneider, Shuling Guo, Scott Henry, Brett Monia, Richard Geary, Yanfeng Wang
Publikováno v:
British Journal of Clinical Pharmacology. 88:5389-5398
Transthyretin-mediated amyloidosis is a progressive and fatal disease caused by the build-up of misfolded transthyretin (TTR) protein. Eplontersen is a triantennary N-acetyl galactosamine (GalNAc3)-conjugated antisense oligonucleotide targeting TTR m
Autor:
Chafic Karam, Julian Gillmore, Gengshi Chen, Nia Jenkins, Mike Hale, Gemma Taylor, Jersey Chen, Nicholas Viney, Eugene Schneider
Publikováno v:
Wednesday, April 26.
Autor:
Teresa Coelho, Márcia Waddington Cruz, Chi-Chao Chao, Yeşim Parman, Jonas Wixner, Markus Weiler, Fabio A. Barroso, Noel R. Dasgupta, Shiangtung W. Jung, Eugene Schneider, Nicholas J. Viney, P. James B. Dyck, Yukio Ando, Julian D. Gillmore, Sami Khella, Morie A. Gertz, Laura Obici, John L. Berk
Introduction: Hereditary transthyretin (ATTRv) amyloidosis is a rare, severe, progressive, debilitating, and ultimately fatal disease caused by systemic deposition of transthyretin (TTR) amyloid fibrils. ATTRv amyloidosis occurs in both males and fem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae5798a91e42710915de5d07acf1a118
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-202005
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-202005
Autor:
PR Newswire
Publikováno v:
PR Newswire US. 01/07/2021.
Autor:
Teresa, Coelho, Márcia, Waddington Cruz, Chi-Chao, Chao, Yeşim, Parman, Jonas, Wixner, Markus, Weiler, Fabio A, Barroso, Noel R, Dasgupta, Shiangtung W, Jung, Eugene, Schneider, Nicholas J, Viney, P James B, Dyck, Yukio, Ando, Julian D, Gillmore, Sami, Khella, Morie A, Gertz, Laura, Obici, John L, Berk
Publikováno v:
Neurology and therapy.
Hereditary transthyretin (ATTRv) amyloidosis is a rare, severe, progressive, debilitating, and ultimately fatal disease caused by systemic deposition of transthyretin (TTR) amyloid fibrils. ATTRv amyloidosis occurs in both males and females. Eplonter